This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products.
Here's Why it is Worth Buying General Electric (GE) Stock Now
by Zacks Equity Research
General Electric (GE) is likely to gain from restructuring efforts, organic growth opportunities in some segments, reduction of debt levels and expansion in emerging markets.
Danaher (DHR) Names New Dental Company Envista Holdings
by Zacks Equity Research
Danaher (DHR) plans to create a separate dental company Envista, which will be listed on the New York Stock Exchange, and is likely to employ 12,000 people globally.
The Zacks Analyst Blog Highlights: Berkshire Hathaway, salesforce, Danaher, Halliburton and American Airlines
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Berkshire Hathaway, salesforce, Danaher, Halliburton and American Airlines
Here's Why it is Worth Holding on to Danaher (DHR) Stock Now
by Zacks Equity Research
Danaher (DHR) stands to gain from solid product portfolio, acquisitive nature and shareholder-friendly policy. High costs and debts as well as forex woes remain concerning.
Top Stock Reports for Berkshire Hathaway, salesforce & Danaher
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Berkshire Hathaway (BRK.B), salesforce (CRM) and Danaher (DHR).
ITT vs. DHR: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
ITT vs. DHR: Which Stock Is the Better Value Option?
CKHUY or DHR: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
CKHUY vs. DHR: Which Stock Is the Better Value Option?
Danaher (DHR) Up 3.4% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Danaher (DHR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
CKHUY vs. DHR: Which Stock Is the Better Value Option?
by Zacks Equity Research
CKHUY vs. DHR: Which Stock Is the Better Value Option?
General Electric (GE) Q1 Earnings Beat Estimates, Down Y/Y
by Zacks Equity Research
General Electric's (GE) first-quarter 2019 results decline year over year due to weak sales performance and fall in margins. However, results surpass estimates.
The Zacks Analyst Blog Highlights: Roche, Danaher, BlackRock, Kinder Morgan and Allstate
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Roche, Danaher, BlackRock, Kinder Morgan and Allstate
Top Research Reports for Roche, Danaher & BlackRock
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Roche (RHHBY), Danaher (DHR) and BlackRock (BLK).
Honeywell (HON) Q1 Earnings & Revenues Outpace Estimates
by Zacks Equity Research
Solid long-cycle businesses in U.S. defense, commercial aerospace, and warehouse and process automation drive Honeywell's (HON) Q1.
Danaher (DHR) Q1 Earnings Top, View Down on Buyout Impact
by Zacks Equity Research
Danaher's (DHR) first-quarter 2019 results gain from sales growth and DBS initiatives. It lowers projection for 2019 to include the dilutive impact of the BioPharma buyout.
Danaher (DHR) to Report Q1 Earnings: What's in the Offing?
by Zacks Equity Research
Danaher's (DHR) first-quarter 2019 results to gain from solid product portfolio, innovative capabilities, Danaher Business System and acquired assets. Forex woes, tariffs and high costs drag.
Danaher (DHR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Danaher (DHR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Top Analyst Reports for Mastercard, Honeywell & Thermo Fisher
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Mastercard (MA), Honeywell (HON) and Thermo Fisher (TMO).
UTX or DHR: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
UTX vs. DHR: Which Stock Is the Better Value Option?
UTX vs. DHR: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
UTX vs. DHR: Which Stock Is the Better Value Option?
Danaher to Gain From Solid Demand in Key Markets Amid Risks
by Zacks Equity Research
Effective implementation of Danaher Business System and solid demand for innovative products are likely to boost Danaher's (DHR) revenues.
Danaher's Stock Offering Proceeds to Fund BioPharma Buyout
by Zacks Equity Research
Danaher (DHR) successfully completes the offering of common and preferred shares. It intends on using the funds raised to pay for the pending acquisition of General Electric's BioPharma business.
GE Intends to Lower Debt Burden, Boost Dividend Payments
by Zacks Equity Research
General Electric (GE) seeks to become more competent on the back of its initiatives to improve financial position and strengthen core businesses.
Danaher to Buy BioPharma, Offers Common & Preferred Shares
by Zacks Equity Research
Danaher (DHR) to gain from the buyout of the BioPharma business. This is likely to strengthen its biologics workflow solutions business. The company offers common and preferred shares.
General Electric (GE) to Divest BioPharma, Closes Wabtec Deal
by Zacks Equity Research
General Electric (GE) to gain from divestiture of the BioPharma business by using the proceeds to lower debt burden and focus on more important portfolios. It completes GE Transportation divestment.
Company News For Feb 26, 2019
by Zacks Equity Research
Companies In The News Are: DHR,GE,ONCE,CMTA,CRI